Cervical cancer continues to be a major public health problem in Bangladesh in the absence of satisfactory and organized cervical screening programs. World Health Organization (WHO) considered cervical cancer as a preventable disease, as it can be identified in the pre-invasive stage. Visual inspection of the cervix with acetic acid (VIA) is an effective, inexpensive screening test that can be combined with simple treatment procedure for early cervical lesions, provided by trained health workers. To evaluate the value of visual inspection with acetic acid (VIA) for early detection of cervical pre-cancer and cancer in low resource country like Bangladesh, diluted acetic acid 5% was applied to the cervix and visual inspection was done. VIA tests were done for at least 3 years interval, in case of married woman, for cervical cancer screening. Women with positive results were sent for colposcopy. From January to December 2014, in Gynae OPD of the Faridpur Medical College Hospital, Faridpur, a total of 2000 women were screened by VIA test. Fourty-one VIA positive cases were identified and referred for colposcopy. Out of 41 cases, 27 patients underwent colposcopic examination, among them CIN-1 was found in 21 cases, CIN-2 in 2 cases and CIN-3 in 2 cases. However, two cases were colposcopically negative. So even during gynecological practice, if we arrange a setup for cervical screening by VIA test, many women can be saved from future development of carcinoma cervix later in their lives.
More than 85% of the global burden occurs in developing countries, where it accounts for 13% of all female cancers 1, 2 . Cervical cancer is a public health problem in developing countries and has enormous social and economic impacts on the population since it often affects women who are within the reproductive age groups 3, 4 . It is the most common female genital cancer in many developing countries. The highest burden of the disease has been reported in Asian, Latin American and African countries 5, 6 . Screening facilities in developing countries for cervical premalignant lesions are few and are mostly concentrated in the urban areas whereas majority of the population resides in the underserved rural areas. Even at the urban centers, there is an absence of high quality cytological services 7, 8 . Many studies now provide evidence of the feasibility and cost-effectiveness of screening and treatment approaches for cervical cancer prevention. These can be easily adopted for various settings [9] [10] [11] [12] [13] [14] [15] .
About 500,000 new cases are identified each year and at least 200,000 women die of this cancer each year. Eighty percent of new cases occur in developing countries, while this is declining in the developed world due to introduction of different screening tests 16 . Bangladesh showed that the prevalence of cancer cervix is 26% amongst all types of cancers affecting female 18 . WHO considers cervical cancer as a preventable disease 19 . The decrease in cervical cancer prevalence in most of the developed countries is attributed to the success of cytology based screening program, but our country often lacks the necessary resource to use pap-smears as a screening tool for cervical abnormalities 20 . As the incidence of cervical cancer is highest in low resource settings, alternative techniques have been sought. Recently, visual inspection with acetic acid (VIA) has gained popularity 21 . The main attractions of this technique are that, unlike conventional cytology, the results of the test are obtained almost immediately. It is relatively cheaper and most of the equipment can be sourced locally. It has been proposed, "To minimize the problems of compliance with the treatment, woman screened with VIA in developing countries should be offered treatment at the same clinic, termed as ''see and treat'' approach 22 .
WHO suggested an alternative, known as "down staging screening", to regular cytological screening as an experimental approach. It can be defined as the detection of the disease at an earlier stage by nurses and other non-medical health personnel using a simple speculum for visual inspection of the cervix 23 . The aim of this study was to evaluate the clinical performance of visual inspection of acetic acid(VIA) as a simple test and if it is a suitable alternative to cytology for early detection of cervical pre-cancer and cancer.
Materials and Methods:
An observational study was done in gynaecology outpatient department in Faridpur Medical College Hospital, Faridpur during the period of January 2014 to December 2014.Total 2000 women were selected randomly. All asymptomatic women between age group 18-60, who were married for at least 3 years, were included in this study. Women with unhealthy suspicious looking cervix or with any cervical growth were excluded from the study. 5% acetic acid was applied for 1 minute to the cervix during routine gynecological examination. Any change of colour (aceto white) was observed. Written informed consents were taken prior to their examination. Women with positive results were referred to higher center for colposcopic evaluation. Information of the patients was collected by data collection sheet. Figure 1, 2 and 3 show the characteristics of the study population. Figure 1 shows, among total 2000 patients, 12 women were less than 20 years of age, 816 were between 21 and 35 years of age and 1188 were more than 35 years of age.
Results:
The results show that well-trained health workers can effectively perform cervical screening, cryotherapy and follow up even with low resources, under medical supervision. In our study, the screen positivity was 2.05%. Previous studies on VIA had the positivity ranged from 6.6%to 27.4% 14, 25 . The average sensitivity of VIA in various studies from low resource settings is 50% (range 14-95) with a specificity of 85% (range . This wide range is due to variation in the women, type of provider and their training [24] [25] [26] .
In this study, about two-third of the cases aged more than 35 years which is comparable with other studies 27, 28 . Those studies indicate CIN is more prevalent in sexually active women 27, 28 . World Health Organization also emphasized on screening the woman aged between 35 and 45 years 29 . However, most of the cases were housewives in this study.
In our study, 72.9% women had less than two children. Highest percentage had experienced menarche at the age of 13 years. Regarding the age of first coitus, 59.4% experienced it before 18 years in our study, whereas Kamrun Nessa et al found 76.5% of their study sample having it before 18 years 30 . Similarly, Sayeeda found that more than 80% experienced first coitus before 19 years of age 27 . Early age of marriage and early first delivery are important demographic factors in development of carcinoma cervix. In this study, age of women during first delivery was less than 19 years in 51.6% cases. This study found that 92.59% had CIN lesions and 7.4% had normal findings which are comparable with other studies 30, 31 . Colposcopically directed punch biopsy revealed 81.48% cases with positive lesions and 18.52% with no lesions in this study which is consistent with a previous study 30 .
Conclusion:
Screening for precancerous and cancerous cervical lesions using VIA is simple, which requires minimal infrastructure and low cost. VIA is an effective alternative to cytological and HPV DNA testing. Direct visualization with acetic acid (VIA) has been proven, in many clinical trials, as an alternative to Pap-smear in developing countries. If we can approach "See and treat" policy, more women can be saved from development of cancer cervix. Total 41 women were found VIA positive who were referred to the higher center for colposcopy and further evaluation. Among them, 14 women denied to go higher center. Remaining 27 women reported to higher center and underwent colposcopy. Table III shows among 27 patients who underwent colposcopy, 21 were diagnosed as CIN I, 2 cases were CIN II, 2 cases were CIN III and 2 were colposcopically negative.
Discussion:
This study reports the experiences of implementing VIA-based cervical screening method in areas where medical facilities are limited. VIA is a simple and affordable screening test with acceptable sensitivity (50-88.6%) and specificity (66.7-89.7%) 24 . 
